EICHOR
● Active Not Recruiting
Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled Asthma
Condition: Asthma · Sponsor: Regeneron Pharmaceuticals
About this study
This study is researching a drug called dupilumab. The study is focused on patients who have uncontrolled asthma. Asthma is a condition where the airways narrow and swell, making it difficult to breathe. Uncontrolled asthma means that patients are still having frequent symptoms while taking their current asthma medication. The aim of the study is to see which regimen is more effective: taking dupilumab with an inhaled asthma medication or only taking a higher dose of the inhaled asthma medication. The type of asthma medication that will be used is a combination inhaled corticosteroid and long-acting beta-agonist (referred to as an ICS/LABA). Some patients may also receive an additional asthma medication called a long-acting muscarinic antagonist (referred to as a LAMA) if they are already receiving a LAMA. The study is also looking at: • What side effects may happen from taking dupilumab
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (77)
| Kern Research, Inc | Bakersfield, California, United States | — |
| Modena Allergy & Asthma, Inc. | La Jolla, California, United States | — |
| Antelope Valley Clinical Trials | Lancaster, California, United States | — |
| Ark Clinical Research, LLC | Long Beach, California, United States | — |
| Newport Native Md, Inc. | Newport Beach, California, United States | — |
| Childrens Hospital of Orange County Main Campus | Orange, California, United States | — |
| Raffi Tachdjian MD, Inc. | Santa Monica, California, United States | — |
| Bensch Clinical Research | Stockton, California, United States | — |
| Integrated Research of Inland, Inc. | Upland, California, United States | — |
| Allianz Research Institute | Westminster, California, United States | — |
| National Jewish Health | Denver, Colorado, United States | — |
| St Francis Medical Institute | Clearwater, Florida, United States | — |
+ 65 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06572228